Global Trac Solutions, Inc. CEO, David Flores, sits down once again with Founder & CEO of The Third Wave, Paul F. Austin. The two begin their conversation with accessibility & affordability, concepts that are commonly overlooked in psychedelic medicine. They then dive into what it would take to create an infrastructure that ensures a very important segment of our society is able to gain access to the powerful, and profound benefits available through the use of psychedelic medicine.
Similar Posts
Psychedelic Start-Up Atai Life Sciences to Raise $100 Million in IPO, 2nd to List on Nasdaq
Atai Life Sciences is now the second psychedelic company to list on Nasdaq, with plans to raise $100 million for its IPO.
Adele LaFrance: Healing Eating Disorders With Psychedelics
Clinical psychologist Adele LaFrance is working with psychedelics like ayahuasca to help treat eating disorders.
Top 5 ‘Joe Rogan Experience’ Episodes About Psychedelics
Yes, Joe Rogan is a subversive. But he’s a subversive who knows a thing or two about psychedelics.
Phase II Study Shows LSD Is Effective In Treating Major Depressive Disorder
Data from a Phase 2 clinical trial involving LSD-assisted psychotherapy show LSD as effective treatment for Major Depressive Disorder.
Creating Inclusive KAP Training Practices: A Conversation with TRIPP Founder Jennifer Montjoy
TRIPP offers in-depth and intimate training courses for new KAP facilitators wishing to integrate ketamine into their psychiatric and psychotherapy practice, as well as holistic experiential retreats for first responders and frontline healthcare clinicians.
40 ‘New’ Psychedelic Compounds Found In More Than 25 Species of Mushrooms
Mydecine Innovations Group says it has found 40 new compounds in at least 25 types of mushrooms with psychedelic and potentially therapeutic properties.